Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?-Reference-Cited by-同舟云学术

Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?

Published:2016-02-11 Issue:5 Volume:54 Page:445-458
ISSN:1369-3786
Container-title:Medical Mycology
language:en
Short-container-title:Med. Myco.

Author:

Girmenia Corrado,Annino Luciana,Mariotti Benedetta,Fanci Rosa,Minotti Clara,Spadea Antonio,Carotti Alessandra,Piedimonte Monica,Chierichini Anna,Cerchiara Elisabetta,Caselli Desiree,Cupelli Luca,Arcioni Francesco,Bertaina Alice,Ribersani Michela,Proia Anna,Mengarelli Andrea,Perriello Vincenzo,Torelli Giovanni Fernando,Di Gioia Massimo,Del Principe Maria Ilaria,Cassetta Maria Iris,Fallani Stefania,Novelli Andrea

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine

Link

http://academic.oup.com/mmy/article-pdf/54/5/445/7949294/myw001.pdf

Reference30 articles.

1. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

2. Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

3. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

4. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

5. Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal Drugs TDM: Trends and Update;Therapeutic Drug Monitoring;2022-02

2. A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication;Therapeutic Drug Monitoring;2021-08

3. Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management;Medical Mycology;2019-02-28

4. The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single Center Study;Turkish Journal of Hematology;2018-07-26

5. Isavuconazole: Case Report and Pharmacokinetic Considerations;Chemotherapy;2018